Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02842281 · ClinicalTrials.gov registry record · NA
Microbiome Fructan Metabolism and Symptoms in Childhood IBS
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT02842281 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 55 participants.
The verdict
NCT02842281, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
This study evaluates whether the gut microbiome is involved in determining whether children with irritable bowel syndrome (IBS) develop worsening GI symptoms (e.g. pain) when given fructans (a sugar often found in wheat). Participants will both receive a diet with fructans and a diet without fructans.
Interventions
- OTHER Maltodextrin
- OTHER Fructan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2014-09 |
| Est. Completion | 2019-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02842281
The ClinicalTrials.gov registry entry for NCT02842281 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Maltodextrin is the first listed.
NCT02842281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02842281 about?
NCT02842281 is a clinical study titled "Microbiome Fructan Metabolism and Symptoms in Childhood IBS". This study evaluates whether the gut microbiome is involved in determining whether children with irritable bowel syndrome (IBS) develop worsening GI symptoms (e.g. pain) when given fructans (a sugar often found in wheat). Participants will both receive a diet with fructans and a diet without fructan...
What is the current status of trial NCT02842281?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2014-09. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02842281?
The interventions under investigation include: Maltodextrin (OTHER), Fructan (OTHER).
Who is sponsoring clinical trial NCT02842281?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.